These findings suggest that obesity impairs vascular and alveolar regeneration by suppressing adiponectin-VEGF/VEGFR2 signaling, and adiponectin may be one of the therapeutic targets to improve regenerative ability in obese lungs. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.